'Immediately open access' option for the leading journal Genome Research

Cold Spring Harbor Laboratory Press announced today that authors of papers in its journal Genome Research can now choose to have their papers made freely available online immediately upon publication. This option will incur a publication surcharge of $1,000.

As a founder member of the DC Principles Coalition (www.dcprinciples.org), Cold Spring Harbor Laboratory Press is committed to making research results as widely available as possible. Papers published in Genome Research can already be read without restriction at the journal's website (www.genome.org) six months after publication and copies of these papers are deposited with the National Libraryof Medicine's database PubMedCentral (www.pubmedcentral.nih.gov). The Press also makes its journals available free of charge online to scientists in the poorest countries through the HINARI (www.healthinternetwork.org) and AGORA (www.aginternetwork.org) projects.

"We are pleased to expand the service we offer the scientific community by making this option available," Dr. John Inglis, Executive Director of Cold Spring Harbor Laboratory Press, commented. "Genome Research is one of the most significant journals in the fields of genetics and genomics. It has a professional, dedicated editorial and production staff and state-of-the-art technologies for peer review, redaction, publishing, and distribution that are funded by a combination of subscription fees from institutions, advertising fees from companies, and author surcharges for color art and page use. If authors alone bore the entire cost of publication, the charge required would be beyond all but the most well-funded scientists, excluding work from many exceptional laboratories worldwide."

Its diversity of financial support is an imp

Contact: Elizabeth Powers
Cold Spring Harbor Laboratory

Page: 1 2 3

Related biology news :

1. Real-time Plant Physiology: ASPB extends open access benefit for members
2. Senior academic officers oppose public access legislation
3. Macrochem acquires option to license pexiganan
4. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
5. Fat stem cells being studied as option for breast reconstruction
6. Drug offers new options for leukemia patients
7. Breast-sparing surgery an option for women with breast cancer gene mutation, U-M-led study finds
8. New treatment option breaks Leukemias resistance to chemotherapy, radiation therapy
9. Avian flu modeled on supercomputer, explores vaccine and isolation options for thwarting a pandemic
10. STN AnaVist 1.1 offers new options for sharing
11. Accentia Biopharmaceuticals announces option agreement with Mayo

Post Your Comments:

(Date:1/7/2020)... ... January 06, 2020 , ... Myant Inc. , the pioneers in Textile ... bring to life its vision of a world where textile-based interfaces knitted into everyday ... digital sphere, and the physical IoT-enabled environment. The experience at Myant’s booth will challenge ...
(Date:12/30/2019)... ... 30, 2019 , ... Cure Now ? Instead of Palliative ... is the 6th leading cause of death in the United States. , ... other dementia. ,     These caregivers provided an estimated 18.5 billion hours of ...
(Date:12/21/2019)... ... ... The City of Tampa recently served as the host location of the ... Tampa welcomed these most-highly decorated USA heroes as the National Hockey League (NHL), The ... members. , The Medal of Honor, the USA military’s highest award for valor in ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 17, 2019 , ... ... its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the company’s inception ... Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) have received 2 ...
(Date:12/18/2019)... ... 18, 2019 , ... Tune in to CNBC on Saturday, December 28th at ... listings for more information on this program. , With a look at Avatar ... complex system to increase the efficiency, safety and effectiveness of equipment, systems, and processes ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... clearance for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein ... great benefits for first-in-line treatment for nonsurgical removal of soft emboli and ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of ... San Francisco (UCSF) with a common goal to generate recombinant antibodies at a ...
Breaking Biology Technology:
Cached News: